Reperfusion-induced arrhythmias were elicited in the pentobarbitone-anaesthetized rat by occlusion of the left main coronary artery and subsequent release. 2 These arrhythmias were rapid in onset, occurring within 20 s after release of the ligature, and were of short duration (1 -2 min). Their severity was dependent upon the duration of the preceding occlusion. A 5 or 15 min occlusion period produced the most severe arrhythmias on release, the incidence of ventricular fibrillation being 56 and 50% respectively. 3 Evidence that reperfusion had occurred was provided by fluorescein dye distribution and intramyocardial temperature studies. 4 The severity of reperfusion arrhythmias and mortality was unaffected by bilateral vagotomy, P-adrenoceptor blockade by atenolol (2 mg kg-' i.v.) or a combination of the two. The incidence of reperfusion-induced ventricular fibrillation was significantly reduced by Org 6001 (which blocks the fast inward sodium current), melperone (which acutely prolongs the cardiac action potential duration) and bepridil (which blocks both fast and slow inward currents). It was unaffected by nitroglycerine and the calcium antagonists verapamil, prenylamine and nifedipine. 6 We have shown that reperfusion-induced cardiac arrhythmias can be consistently elicited in the anaesthetized rat and that they are particularly susceptible to drugs that can block the fast inward sodium current.
Introduction
It has been known for some time that in experimental animals restoration of blood flow to the myocardium, after a brief period of ischaemia, is associated with the occurrence of severe ventricular arrhythmias (Sewell et al., 1955) . More recently, it has been suggested that such reperfusion-induced arrhythmias may be of clinical importance since it has been shown that sudden cardiac death, due to ventricular fibrillation, is not always accompanied by a permanent obstruction of a coronary artery (Schaffer & Cobb, 1975) . In man, release of coronary artery spasm or platelet disaggregation causing restoration of blood flow to a previously ischaemic region of the myocardium could be the underlying cause of ventricular fibrillation and sudden cardiac death.
Experimentally such arrhythmias have been studied either in large animals in vivo (Corbalan et al., 1976; Penkoske et al., 1978) or in vitro using Langendorff-perfused rat hearts (Lubbe et al., 1978) . The aim of this study was to develop a model for the production of reperfusion-induced arrhythmias in the rat in vivo which could be used to assess the effectiveness of a variety of drugs in protecting against this type of arrhythmia. A preliminary account of these results has been presented to the British Pharmacological Society .
Methods
Male Sprague-Dawley rats (220 g-350 g) were anaesthetized with sodium pentobarbitone, 60mgkg-1 administered intraperitoneally. The femoral vein was cannulated to allow drug and dye administration, and the trachea for artificial respiration. Systemic blood pressure was monitored from the carotid artery by means of a Statham P23 1D transducer. A standard lead 1 ECG was recorded, together with systemic blood pressure, on a Mingograf 82 ink jet recorder (Elema-Schonander, Stockholm) .
The chest was opened using a left thoracotomy, followed by sectioning of ribs 4 and 5, approximately 2 mm to the left of the sternum. Positive pressure artificial respiration was started immediately with room air, using a volume of 1.5 ml 100 g-1 and a rate of 54strokesmin-t to maintain normal PCO2, P02 and pH parameters. After incising the pericardium the heart was eased out of the chest, using gentle pressure on the rib cage. A 6/0 braided silk suture attached to a 10 mm micropoint reverse cutting needle (mersilk W8 12, Ethicon) was placed under the left main coronary artery, as described by Selye et al. (1960) . The heart was replaced in the chest and the animal left to recover for 15 min. Any animal in which this procedure produced arrhythmias or a sustained fall in blood pressure to less than 70 mmHg was discarded.
A small plastic button was threaded through the ligature and placed in contact with the heart. The artery could then be occluded by applying tension to the ligature and reperfusion achieved by releasing the tension. The coronary artery was occluded for periods of up to 30 min before release in order to assess the effect of duration of occlusion on the severity of reperfusion arrhythmias. In a few animals only, release of the ligature had to be delayed for up to a maximum of 30 s to ensure that the animal was in sinus rhythm at the time of reperfusion. In the first series of experiments electrocardiographic recordings were continued for a period of 30 min after starting reperfusion. However, since no further arrhythmias occurred between 10 and 30 min, the observation period was reduced to 10 min postreperfusion in all subsequent experiments.
Two studies were undertaken to determine whether reperfusion was in fact occurring. In the first of these 0.1mllOOg10 (body wt.) of a 10% w/v solution of fluorescein (Aldrich Chemical Co.) was administered intravenously, immediately after release of the ligature. The heart was rapidly removed from the chest and placed in ice cold KCl solution (10% w/v) for 1 min to stop it beating. A gross examination of the heart was made under u.v. light to determine whether areas of non-perfused myocardium were present. These appeared dark blue under u.v. light whereas perfused areas were stained green. The hearts were then photographed under u.v. light to give a permanent record. As a comparison this procedure was also carried out in hearts with a permanent ligation, after 5 min of ischaemia.
For the second study thermocouples were used to detect temperature changes in the myocardium (n= 8) during occlusion and reperfusion. A copperconstantan thermocouple (SWg 40) was inserted into the myocardium of the left ventricle below the site of occlusion, at the same time as insertion of the ligature. A reference thermocouple was present in the rectum. Fifteen minutes later the artery was occluded for 5 or 10 min, followed by reperfusion. Changes in myocardial temperature were monitored using a Kipp and Zonen recorder.
In order to determine whether autonomic neural influences on the heart were important in the genesis 
Statistical analysis
Statistical analysis of differences in the incidence of arrhythmias and in the mortality was carried out using a Chi squared test. For changes in haemodynamic parameters a paired Student's t test was used.
Results
Characteristics of the arrhythmias induced by reperfusion and the relationship between the duration ofocclusion and theirseverity
The arrhythmias that occur upon occlusion of the coronary artery start within 2-4 min and last for about 20 min. Following different periods of occlusion, 5, 15 or 30 min, reperfusion elicits arrhythmias within 8-26 s which continue for only 1-2 min. Ventricular tachycardia (VT) is usually observed and is often followed by ventricular fibrillation (VF), which is not always terminal in the rat since spontaneous reversion to sinus rhythm can occur. Figure 1 shows a typical trace upon release of the ligature after a 5 min occlusion period. Evidence that these arrhythmias are not merely a continuation of those initiated by occlusion is shown in Table 1 . It compares the severity of the arrhythmias which occur during the first minute of reperfusion after either a 5 or 15 min occlusion period with those that occur during the corresponding time periods but with the occlusion still present. The arrhythmias that occur during reperfusion are clearly more serious than those that occur, over the same period, during ischaemia alone. In this model the severity of the reperfusioninduced arrhythmias is related to the duration of the preceding occlusion (Table 2 ). The most severe arrhythmias occur after an occlusion period of 5 or 15 min when 56 and 50% of the animals developed VF respectively. If the duration of occlusion is shortened to 2 min or extended to 20 min the number of arrhythmias is markedly reduced and no VF occurred. During occlusion the most severe arrhythmias are observed between 5 and 20 min post-ligation. followngcoronary artery occlusion Effect ofantiarrhythmic agents on reperfusioninduced arrhythmias
The effect of Org6001, melperone and nitroglycerine on the incidence of VT, VF and mortality following reperfusion is shown in In animals administered the solvent alone, the severity of the arrhythmias is less than in saline controls. Table 5 summarises the effects of the calcium channel blockers, bepridil, verapamil, prenylamine and nifedipine on the incidence of these arrhythmias and mortality. Bepridil was the only drug to be effective against reperfusion-induced arrhythmias. The incidence of VT is significantly reduced by both doses of the drug and VF by the higher dose only.
Haemodynamic effects of the antiarrhythmic drugs
Both Org 6001 and melperone reduced heart rate in these experiments. It fell from 398 ± 21 to 346 ± 17 beats min-' following the administration of Org6001, 10mgkg'1. A similar reduction is observed with the lower dose of melperone whilst the higher dose causes a more marked fall from 429 ± 18 to 284 ± 22 beats min-. These changes are all statistically significant (P<0.01). Arterial blood pressure is not significantly reduced by Org 6001 whereas with the higher dose of melperone it falls from 95 ± 7 to 56±llmmHg (P<0.05). Similarly, nitroglycerine causes a sustained fall in blood pressure from 84 ± 11 to 63 ± 1 mmHg (P<0.01) before occlusion, as does its solvent, 94 ± 7 to 81 ± 2mmHg. Nitroglycerine administration does not alter heart rate. The calcium antagonists, with the exception of bepridil, cause no changes in heart rate. Bepridil, 5mg kg-, reduces heart rate from 384 ± 20 to 340 ± 12 beats min-1. A maintained fall in arterial blood pressure is observed only after the adninistration of 25ugkg-1 of nifedipine (82±4 vs 72 ± 3 mmHg at 10 min post-injection). The other calcium antagonists did tend to cause a fall in blood pressure on injection but these changes are transient. On occlusion, the changes observed in blood pressure in these drug-treated animals are similar to those recorded in the control group. 
Discussion
This study demonstrates that reperfusion-induced cardiac arrhythmias can be reliably and consistently produced in the anaesthetized rat. One of the most distinctive features of these arrhythmias in this model is their rapid onset and short duration when compared with those that occur when the occlusion is present. A similar profile of reperfusion-induced arrhythmias has previously been described in larger animals (Axelrod etaaL, 1975; Penkoske etaaL, 1978) . Another similarity observed between this and the larger animal models is the pattern and severity of the arrhythmias. Following reperfusion, ventricular tachycardia occurred within 30 s and rapidly degenerated into fibrillation in many instances. In contrast, arrhythmias which occur during occlusion generally begin with isolated ectopic beats which may or may not lead to fibrillation.
The severity of these arrhythmias was dependent upon the duration of the occlusion, as has been noted both in the dog in vivo (Balke etal., 1981) and in the . Release of the occlusion after a 5 or 15 min ischaemic period led to the most severe arrhythmias with 56 and 50% of the animals fibrillating respectively. Following longer periods of occlusion e.g. 30 min, no fibrillation was observed upon reperfusion. We think that this reduced severity of the arrhythmias following longer periods of ischaemia is not due to failure to reestablish blood flow to the myocardium since the studies carried out with fluorescein dye indicate that most of the left ventricle is perfused irrespective of the duration of the occlusion. However since these studies were carried out in a limited number of animals, we cannot state categorically that rapid reperfusion occurred on release in every instance. Supportive evidence that blood flow was being reestablished on reperfusion was provided by the measurement of temperature of the ischaemic myocardium. Whilst occlusion was accompanied by a rapid fall in temperature, reperfusion led to a sharp rise, indicating a return of blood flow and increase in metabolic activity. The rat does differ from other species, in this respect, in that e.g. in the dog, arrhythmias can be elicited following occlusion periods of up to 60 min. It may be that due to the much faster heart rate of the rat, cells in the ischaemic area die faster and hence the tissue is electrically inexcitable by 20-30 min post-ligation. Indeed by this time, even if the occlusion is still present, the early arrhythmias have virtually ceased (Clark et al., 1980) . The 5 rather than 15 min occlusion period before release of the ligature was selected for further experiments thus avoiding the exclusion of animals from the reperfusion study which died during the occlusion phase.
We have also shown in this study that such reperfusion-induced arrhythmias in the rat are unaffected by bilateral vagotomy, P1-adrenoceptor blockade with atenolol or a combination of the two. It would seem unlikely, therefore, that the autonomic nervous system plays a major role in the genesis of these arrhythmias. This is in contrast to occlusioninduced arrhythmias in both the cat and the rat, the severity of which has been shown to be reduced by removal of both parasympathetic and sympathetic nervous influences (Gillis, 1971; Harris etal., 1982) .
Comparable studies relating to the effects of vagotomy either alone or in combination with Pblockade specifically on the severity of reperfusioninduced arrhythmias do not appear to have been done in other species. However, it has been shown that P-adrenoceptor blocking agents per se do not appear to protect against this type of arrhythmia (Sheridan et aL, 1980; Williams et aL, 1982) . Furthermore, propranolol was ineffective in preventing the change in ventricular fibrillation threshold observed following reperfusion (Corbalan et al., 1976) supporting our observation that P-blockade is not protective against this type of arrhythmia.
The drugs which we found to be effective antiarrhythmics in this model were Org 6001, melperone and bepridil. As in the rat in vivo both Org 6001 and bepridil have been shown to prevent reperfusioninduced fibrillation in the perfused isolated heart of the rat Marshall et al. 1982 ). This antiarrhythmic action of Org 6001 is likely to be related to its ability to reduce the fast inward sodium current in cardiac tissue, a Class I effect according to the Vaughan Williams classification (Salako et al., 1976) . Other Class I antiarrhythmic drugs such as lignocaine, quinidine and procainamide have also been shown to reduce the severity of reperfusion induced arrhythmias in the rat (Lubbe et al., 1978; Bergey et al., 1982) although in the dog confliciting results concerning their effectiveness have been obtained (Naito et al., 1981; Bergey et al., 1982) .
Melperone and bepridil also share this property of reducing the fast inward sodium current in cardiac tissue (Kane & Winslow, 1980; Millar & Vaughan Williams, 1983 ) but they have other effects which might underly their antiarrhythmic actions. For instance, melperone is an a-adrenoceptor blocking agent (Peterson, 1981) and it prolongs the duration of the cardiac action potential (Arlock, 1978) . Both of these actions may contribute to the marked protection against reperfusion-induced arrhythmias since drugs with similar properties such as prazosin (Sheridan etal., 1980) and amiodarone (Lubbe etal., 1979) have also been reported to be effective. Bepridil is also a calcium channel blocker (Vogel et al., 1979) but the fact that the other calcium antagonists studied were ineffective in this model suggests that in the case of bepridil, its effects on the fast sodium channel may be of more importance. It should also be noted, that in doses which were antiarrhythmic in this study, Org 6001, melperone and bepridil all significantly reduced heart rate. A reduction in heart rate, per se, however, cannot be the basis of their antiarrhythmic action since atenolol also had a marked negative chronotropic effect but was not antiarrhythmic. This does not of course exclude the possibility that these drugs may be acting by suppression of abnormal automaticity in the myocardium.
Nitroglycerine was found to be ineffective against these reperfusion-induced arrhythmias. This is in contrast to the results obtained by Stockman et al. (1979) who reported a reduction in the incidence of reperfusion fibrillation in the dog particularly when nitroglycerine was administered with phenylephrine. It may be that in our experiments any possible antiarrhythmic effect of the drug was masked either by the unusually low incidence of fibrillation in the solvent control group or by the rather marked fall in arterial blood pressure observed, which presumably in the experiments of Stockman et al., (1979) was coun-356 K.A. KANE, et al. teracted by the simultaneous administration of phenylephrine.
The other calcium antagonists studied, verapamil, nifedipine and prenylamine were also not antiarrhythmic in this model. In the case of both nifedipine and verapamil some dog studies have shown protection (Brooks et al., 1980; Coker & Parratt, 1983) whilst others have not (Ribeiro et al., 1980; Naito et al., 1981) . In the isolated working heart of the rat, prenylamine but not nifedipine reduced the severity of reperfusion arrhythmias and prenylamine has also been shown to protect against the fall in ventricular fibrillation threshold observed upon reperfusion in the dog (Schoeneberger et al., 1979) . These conflicting results may be due to differences in species, in doses used, or it may be that the size of the ischaemic area is crucial to the beneficial effect of this type of drug. For instance, in the in vitro studies with prenylamine, a concentration high enough to exhibit Class I antiarrhythmic activity was used but we have observed that in the rat in vivo, such concentrations cannot be studied due to their marked vasodepressor actions. At the concentrations used in the present study, all of these calcium antagonists (i.e. verapamil, nifedipine and prenylamine) reduce the severity of the early arrhythmias that occur when the occlusion is present (Fagbemi & Parratt, 1981; Fagbemi et al., 1983) . This suggests that these reperfusion-induced arrhythmias show a different sensitivity to drugs with calcium channel blocking activity than those which occur upon occlusion, but are similarly influenced by drugs that possess Class I antiarrhythmic activity . In summary, therefore, we have described a model which consistently elicits a high incidence of reperfusion-induced arrhythmias in the anaesthetized rat. These arrhythmias, in contrast to those that occur when the occlusion is present, do not appear to be influenced by alterations in autonomic nervous activity or by administration of calcium channel blocking drugs. However, drugs that block the fast inward sodium channel are effective, particularly in reducing the incidence of reperfusion-induced ventricular fibrillation.
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